Next Article in Journal
From Interferon to Checkpoint Inhibition Therapy—A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette–Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC)
Next Article in Special Issue
The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
Previous Article in Journal
Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
Previous Article in Special Issue
Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist
 
 
Article

Article Versions Notes

Cancers 2022, 14(3), 693; https://doi.org/10.3390/cancers14030693
Action Date Notes Link
article xml file uploaded 29 January 2022 10:00 CET Original file -
article xml uploaded. 29 January 2022 10:00 CET Update https://www.mdpi.com/2072-6694/14/3/693/xml
article pdf uploaded. 29 January 2022 10:00 CET Version of Record https://www.mdpi.com/2072-6694/14/3/693/pdf
article supplementary file uploaded. 29 January 2022 10:00 CET - https://www.mdpi.com/2072-6694/14/3/693#supplementary
article html file updated 29 January 2022 10:01 CET Original file -
article html file updated 29 January 2022 10:07 CET Update -
article html file updated 31 July 2022 07:43 CEST Update https://www.mdpi.com/2072-6694/14/3/693/html
Back to TopTop